0000950170-24-017071.txt : 20240220 0000950170-24-017071.hdr.sgml : 20240220 20240220160017 ACCESSION NUMBER: 0000950170-24-017071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sperzel John J III CENTRAL INDEX KEY: 0001602618 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 24653089 MAIL ADDRESS: STREET 1: 61 CRESTVIEW LANE CITY: BRUNSWICK STATE: ME ZIP: 04011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 ownership.xml 4 X0508 4 2024-02-20 0001492674 T2 Biosystems, Inc. TTOO 0001602618 Sperzel John J III 101 HARTWELL AVENUE LEXINGTON MA 02421 true true false false See Remarks false Common Stock 2024-02-20 4 M false 160 A 333 D Restricted Stock Units 2024-02-20 4 M false 160 0 D Common Stock 160 160 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On February 20, 2022 the reporting person was granted 480 RSU's that vest in three equal annual installments commencing on February 20, 2023 Chairman, President and Chief Executive Officer /s/ John Sprague, Attorney-in-fact 2024-02-20